ArticleClinical drug investigation2023

Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021.

Young Eun Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.